Skip to main content
Premium Trial:

Request an Annual Quote

Agilent, ISB to Collaborate on Multiple Reaction Monitoring Atlas

NEW YORK (GenomeWeb News) – Agilent Technologies and the Institute for Systems Biology announced today that they will collaborate in developing the Human Multiple Reaction Monitoring Atlas, a resource designed to enable scientists to perform quantitative analysis of all human proteins.

The collaboration is supported by a $4.6 million National Human Genome Research Institute grant to ISB Director of Proteomics Robert Moritz and ISB President Lee Hood as part of the American Recovery and Reinvestment Act. Also participating in the project is Ruedi Aebersold of the Swiss Federal Institute of Technology (ETH), with additional funding coming from the European Research Council.

The project, to be conducted over two years, will use Agilent's triple quadrupole and quadrupole time-of-flight liquid chromatography/mass spectrometry systems and nanoflow HPLC-Chip/MS systems at ISB in Seattle and at ETH in Zurich.

"We believe this will be a revolutionary development in protein analysis," said ISB's Moritz in a statement, "one that will accelerate and catalyze the routine use of protein quantitation for immensely important breakthroughs in the understanding, early detection and monitoring of human disease."

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.